Anthropic IPO: November Listing, $2 Trillion Valuation Talk, and How to Buy In

By Muhammad Ramzan Aatish

Two reports landed two days apart and together turned the Anthropic IPO from a rumor into the biggest capital-markets story in AI. First the Journal moved the date and named the terms: a November listing, a valuation near $2 trillion, a raise of up to $100 billion. Then Reuters added the twist nobody expected: Anthropic is debating whether to ship a new AI model before it lists, pushed by a rival’s release and pulled by its own CEO’s call to slow down. If you’re following the Anthropic IPO, this is the reported record: what’s been verified, what the numbers underneath look like, and what would have to be true for any of it to hold.

One thing to get straight before the numbers: almost everything in this story is reported, not confirmed. Anthropic filed confidential IPO paperwork earlier this year, so the public has seen none of the audited financials. The valuation, the raise, the date, the underwriters, even the ticker are all attributed to investors, bankers, or people familiar with the plans. Treat every figure below as a reported figure, and the story reads cleanly.

Why November won over October

The original target was October. The Journal’s reporting says advisers pushed it to November for a plain investor-relations reason: a November listing lets Anthropic put a full third quarter of results in front of investors before pricing, instead of asking the market to extrapolate from a partial one. When your revenue is compounding as fast as Anthropic’s reportedly is, every extra month of actuals makes the bankers’ job easier.

The date could still move. Two people familiar with the matter told Reuters the listing might slip past the midterm elections, a delay nobody involved expects to damage the offering. Roadshow marketing and the public filing were both expected within weeks of the timeline news, but neither is locked. The only fixed point in the calendar so far is the confidential filing itself, submitted earlier this year.

The machinery around the deal is taking shape: Morgan Stanley and Goldman Sachs are reported to be leading the placement, with JPMorgan and Citigroup supporting, and a $15 billion revolving credit facility is being finalized for extra liquidity ahead of the debut. A proposed ticker has surfaced in IPO-tracking coverage, but until the filing goes public there’s no confirmed share count, price range, ticker, or underwriter list. Anyone selling certainty about the terms of this Anthropic IPO is selling something that doesn’t exist.

What $2 trillion is actually anchored to

The number everyone quotes is $2 trillion, and the honest thing to say first is that it’s a discussed number, not a fixed one: the Financial Times reports it is not formally fixed inside the company. It reflects what investors and bankers are talking about, anchored to a revenue trajectory defying ordinary financial vocabulary.

The reported figures: roughly $9 billion in annualized revenue at the end of last year, $47 billion by late spring, $65 billion by the end of the summer, past $100 billion by the time the November timeline broke, with investors expecting $110 billion-plus by year-end. That’s roughly elevenfold growth in under a year, a run rate doubling about every two months. The second quarter alone reportedly brought in $11.5 billion against $787 million a year earlier.

Here’s where it gets interesting for anyone judging the Anthropic IPO on merits rather than headlines. One investor briefed by the banks told the FT the $2 trillion target is “the incredibly low end” of reasonable, arguing that at thirty times revenue the company would be worth $3 trillion. At $110 billion of revenue, $2 trillion works out to roughly eighteen times revenue. Run the same target against the summer figure and it’s just over thirty times. The multiple hasn’t moved; the denominator keeps growing underneath it. When I lined up that math against an independent analysis of the same figures, the conclusion was identical both ways: every extra month of growth this fast makes the valuation easier to defend, which is the logic behind waiting.

There’s a profitability subplot that matters more than the multiple debate. The company has told investors it expects a second consecutive quarter of adjusted operating profit, on a metric that excludes stock-based compensation, with gross margins above 80 percent before partner revenue-sharing. If even approximately true, it answers the oldest objection to this Anthropic IPO: that frontier AI labs can’t make money. A profitable, high-margin company growing revenue several-fold a year is a very different pitch.

One definitional caution, because it matters: “annualized run rate” is not revenue. It takes one strong month or quarter and stretches it across a full year. It’s a useful shorthand, but none of these figures come from audited statements. The public filing, when it lands, will confirm or puncture every number in this section.

From $61.5 billion to $2 trillion: the money trail

The IPO target looks less abrupt once you see the last two years of private valuations. Anthropic was valued at $61.5 billion early last year, $183 billion by that fall, $380 billion after a $30 billion round early this year, and $965 billion after a $65 billion round in late spring. Secondary markets have reportedly priced the shares higher still, around $1.05 to $1.2 trillion. A $2 trillion debut would roughly double the last private price in about half a year.

The late-spring round is the one to understand: led by Altimeter, Dragoneer, Greenoaks, and Sequoia, with institutional co-leads and strategic money from Amazon, Micron, Samsung, and SK Hynix. Part of the headline figure was previously committed infrastructure investment, not fresh equity. Three of those names sell Anthropic the memory and infrastructure it needs to run its models: a slice of that “external” capital flows from companies that profit again when it’s spent.

The cap table behind an Anthropic IPO has two giants on it. Amazon holds about 21 percent of the company and Alphabet about 15 percent, stakes that date to the recent funding rounds. Alphabet’s own quarterly filing carries its private-company stakes at $124.3 billion, primarily Anthropic, against a total cost of $47.6 billion, the rest being markup from other people’s funding rounds. A listing would reprice that stake at the market’s number every quarter: paper gains, not cash, unless Alphabet sells. And Nvidia is reportedly in talks to buy up to $10 billion of the IPO as an anchor investor, a deal still being negotiated, which would put the company’s biggest GPU supplier on its own cap table.

The money is chasing compute. Alongside the funding came agreements for five gigawatts of capacity with Amazon and five gigawatts of TPU capacity with Google and Broadcom, with SpaceX named as a GPU access partner. Investors expect Anthropic’s compute footprint to reach about five gigawatts by year-end and double a year later, roughly the output of several large power plants. That buildout is the physical form of the IPO bet, and it rhymes with the broader AI data center buildout now underway across the industry.

The Astra problem: why a new model is even on the table

The second report was the week’s real surprise. Three sources told Reuters that Anthropic is considering releasing a new AI model ahead of the listing, driven by competitive pressure from OpenAI’s GPT-6 Astra. The company declined to comment; the piece describes deliberations, not a decision, with the next model still being evaluated for safety.

The pressure is measurable, which is what makes this more than gossip. Astra, released early this month, gained fast traction in enterprise and developer channels, Corporate-spend tracker Ramp puts Astra at about 13 percent of tracked enterprise AI spending against about 8 percent for Claude’s Fable line, while developer platform OpenRouter recorded its first week in more than two and a half years in which users spent more on OpenAI’s models than Anthropic’s. I checked the two datasets behind those claims, and what struck me is that they’re fully independent systems: one reads corporate card spend, the other reads API routing traffic, both moving the same direction inside the same few weeks. That’s the kind of coincidence Anthropic IPO investors notice.

Astra’s launch had an unusual edge: it was the first OpenAI model to hit the “Critical” tier under the company’s safety framework, which triggered deployment restrictions and a staged rollout through vetted enterprise customers rather than a normal wide release. Altman told one outlet the model represented “a new capability level” that had already changed his own workflows. Anthropic’s enterprise lead, built on coding and reasoning performance, is being tested in the open for the first time in a while.

The counter-argument deserves equal weight. Existing investors told Reuters they don’t see Astra as a major threat, for boring reasons: Anthropic’s lead in enterprise AI tooling is large, and unseating an incumbent vendor at a big company takes a long time. There’s also pressure from below: open-source models lowering token costs, Chinese labs narrowing the gap, and rising rates pushing investors to ask harder questions about profits. The model debate is happening inside a market where every AI company’s path to profit is being priced in real time.

Meanwhile Anthropic has been expanding what Claude is for. The company recently folded its Cowork assistant into the main chat interface and launched Docs and Slides, pushing Claude deeper into everyday office work, the same enterprise surface where the Astra fight is happening. Our breakdown of the Cowork merge and the Docs and Slides launch covers what that expansion means for the product. A new flagship model would be the capstone of that push, and not coincidentally the centerpiece of an IPO roadshow.

The slowdown CEO on an IPO clock

The strangest thing about this Anthropic IPO is who’s presiding over it. Earlier this month, CEO Dario Amodei published a long essay arguing the industry must slow down: “We must slow the pace at which we improve the capabilities of AI models.” The piece drew public backing from both Altman and Musk. In a Sunday-morning interview the next day, Amodei said people had already tried to misuse Claude to build bioweapons, adding that he’d rather be mocked than learn someone had used Claude to kill people.

There’s no clean way to reconcile that posture with a company reportedly debating rushing a new model out the door to counter a rival before a listing. Or rather, the tension is the story. Anthropic was founded by former OpenAI researchers on the premise that safety requires building the most capable models responsibly, and the Anthropic IPO will test whether that premise survives contact with public-market incentives. Our look at the industry-wide slowdown pledge traces how Amodei’s call, and the backing it drew, became the industry’s defining debate this month.

Anthropic’s own alignment science lead, Evan Hubinger, published a statement this month saying the company has no plan to solve alignment for superintelligence and isn’t clearly on track to develop one, adding his personal estimate of AI-caused human extinction within the decade: above ten percent. A pretraining researcher, Jacob Coxon, who spent three years across Anthropic and OpenAI resigned the same week, warning the companies are “racing straight to self-improving superintelligence and gambling with our lives”; his resignation post was reportedly viewed more than 155 million times and drew a wave of supporting statements from other researchers. The company hasn’t publicly responded to either.

To be fair, Anthropic has put money behind the safety side of its identity. The company and Accenture committed at least $2 billion over five years ($1 billion each) to independent evaluation of frontier models, with Accenture’s Faculty unit leading red-teaming and alignment work. The unusual part is the structure: evaluators get embedded inside Anthropic with employee-comparable access during training and deployment decisions, instead of testing finished systems from outside. Whether that scrutiny survives the transition to quarterly earnings is one of the open questions this Anthropic IPO will answer.

One more detail from the Journal’s reporting: the November decision came before the safety debate erupted, and Anthropic’s advisers argue a slower model pace is unlikely to dent the financials because existing models already generate the revenue. The company also disclosed that Claude now handles about 26 percent of Anthropic’s own R&D work. And at a recent investor gathering, executives showed off something called Model Hardware Standard, a framework for letting AI agents operate physical equipment like microscopes and robotic arms. The IPO, in other words, is asking the market to price both the current business and a much stranger future.

Two labs, two calendars

Anthropic and OpenAI are running visibly different playbooks on the road to the public markets, and the contrast clarifies what each is optimizing for.

The table flatters neither company completely. Anthropic has the nearer-term catalyst and the cleaner safety narrative, but it’s reportedly losing momentum in the developer ecosystem that made it. OpenAI has the momentum but has taken itself out of this year’s IPO window, and its own financing talks suggest it needs enormous capital too. One pattern I keep coming back to: both are racing to convert research leads into durable revenue before the market decides what any of this is worth. The Anthropic IPO is in effect competing with OpenAI’s financing round for the same pool of institutional capital.

Can you buy in before the listing?

Short answer: probably not directly. Anthropic is still private: no ticker, no public quote, no way to buy through a normal brokerage account. The narrower paths each come with a catch.

Secondary markets like Forge Global and Hiive facilitate trades in private-company shares, but access is generally limited to accredited investors and pricing is volatile and opaque. Indirect exposure is possible through the big backers (Amazon and Alphabet both hold large stakes), but their shares carry every other business those companies run, so the Anthropic exposure is heavily diluted. Thematic AI ETFs are marketed as exposure vehicles, though their actual Anthropic holdings vary. For most people, the realistic path into the Anthropic IPO is waiting for the listing.

The honest cautions: no public filing yet means no confirmed share count, price range, or ticker. The underwriter list is reported, not confirmed. Nvidia’s anchor investment is still being negotiated. The $2 trillion valuation is discussed, not fixed. Watch for the public filing, especially the risk-factors section (where Anthropic will have to describe its safety concerns in legally binding language), and for whether Nvidia’s stake is confirmed by name. That’s the useful work right now: reading, not trading.

The three things that actually matter from here

First, the filing. When the S-1 goes public, every reported number in this story gets confirmed or punctured: the revenue, the margins, the compute commitments, the customer concentration. The risk-factors section will be the most revealing document the company has ever published, because it has to describe the safety concerns in legal language.

Second, the anchor. If Nvidia’s up-to-$10 billion investment is confirmed by name in the filing, it lands on top of a valuation that has roughly doubled since the talks were first reported, a GPU supplier buying into its biggest customer at the top of the market. Regulators and competitors will both read that line carefully.

Third, the third quarter: the whole reason for November is a fresh set of actuals. If the quarter matches the run rate, the bankers’ multiple gets easier to defend and the Anthropic IPO prices into strength. If it doesn’t, every skeptical question about run-rate math gets asked at the worst possible moment. The company’s revenue is growing faster than the news cycle covering it; November is a bet that the trend holds for one more quarter.

FAQ

When is the Anthropic IPO expected to happen?

November is the reported target, moved from October so the company can show a full third quarter of results before pricing. It could slip further (even past the midterm elections); none of the terms are confirmed until the public filing lands.

What valuation is Anthropic targeting?

Around $2 trillion, with a raise of up to $100 billion. The figure is discussed, not fixed. One investor called it “the incredibly low end,” arguing 30x revenue implies $3 trillion. At the reported $110 billion year-end run rate, $2 trillion is about 18 times revenue.

Can I buy Anthropic stock before the IPO?

Not directly. The company is private, so there’s no ticker and no public shares. Accredited investors can use secondary platforms like Forge Global or Hiive, where pricing is opaque. Everyone else can get diluted exposure through backers like Amazon and Alphabet, or simply wait for the listing. Practical tip: read instead of trading; the filing’s risk-factors section will tell you more than any price target.

Why did the IPO move from October to November?

So investors see a full quarter of results before pricing. When your revenue doubles every couple of months, each extra month of actuals makes the valuation easier to defend. Boring reason, smart trade.

Is the $2 trillion valuation confirmed?

No. It’s the number investors and bankers are discussing, and the Financial Times reports it isn’t formally fixed inside the company. What’s confirmed: the confidential filing and the revenue trajectory. Everything else is reported, not settled.

How does Anthropic’s IPO compare with OpenAI’s plans?

They’re on opposite calendars. Anthropic is targeting November at a discussed $2 trillion; OpenAI’s CEO has ruled out a 2026 listing and is instead in early financing talks above $1.2 trillion after raising $120 billion-plus. Anthropic leads on reported revenue; OpenAI has the recent product momentum. Both are racing to turn research leads into durable revenue before public markets price them.

Sources

• Reuters, Anthropic preparing November IPO of up to $100 billion, WSJ reports
• Reuters, Anthropic considers releasing new AI model ahead of IPO, sources say (three sources; deliberations, not a decision; company declined to comment)
• Financial Times, Anthropic investors expect $2tn+ listing (paywalled; the $2 trillion exclusive: six backers, “incredibly low end” quote, valuation not formally fixed)
• PYMNTS, Anthropic preparing for Nasdaq listing with proposed ANTH ticker
• BeBeez, Anthropic IPO at $2 trillion and the $65 billion Series H behind it
• temperature2, Anthropic IPO November timing and valuation math
• Eastern Herald, Anthropic IPO: November, $2 trillion valuation analysis
• Motley Fool, Why Anthropic’s IPO timing may relate to Nvidia’s $10 billion anchor investment
• TheStreet, AI model comparison: Claude Fable vs GPT-6 Astra
• Datafloq, Anthropic vs OpenAI: the race to train new frontier models
• Deccan Founders, Anthropic IPO report: OpenAI, Anthropic ticker
• The Wall Street Journal, Anthropic IPO, public listing, November (paywalled; verified via search excerpt)
• TheCable, Anthropic eyes November IPO with $100 billion raise

That’s the state of the Anthropic IPO: a reported November date, a discussed $2 trillion valuation, and audited numbers still to come. Everything in this story gets re-priced the day the filing goes public.